نتایج جستجو برای: hepatotoxicity

تعداد نتایج: 7444  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Robert A B van Waterschoot Rhandy M Eman Els Wagenaar Cornelia M M van der Kruijssen Hilde Rosing Jos H Beijnen Alfred H Schinkel

PURPOSE: Trabectedin (Yondelis, ET-743) is a novel anticancer drug with potent activity against various tumors. However, dose-limiting hepatotoxicity was observed during clinical trials. Because recent reports have suggested that cytochrome P450 3A (CYP3A), as well as the drug transporters ABCB1, ABCC2, and ABCC3 might protect against trabectedin-mediated hepatotoxicity, we investigated the ind...

Ebrahim Azizi Hosein Khalili, Kheirollah Gholami, Mahboobeh Hajiabdolbaghi Mohammad Sistanizad, Reza Mahjub,

The aim of this study was to determine the association of n-acetyltransferase-2 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Iranian pulmonary tuberculosis patients. Acetylating phenotypes was studied in 50 Iranian pulmonary tuberculosis patients using metabolic ratio of plasma acetyl-Isoniazid to Isoniazid. The association between hepatotoxicity and the n-acetyltransferas...

Journal: :گوارش 0
nasser ebrahimidaryani mohammadreza keramati narges ebrahimidaryani mohammad bashashati

background : lindane is an insecticide which is used in commercial insecticides and food containers. caseâ presentation : herein, we reported on a 62-year-old man with liver cirrhosis 12 years after continuous exposure to lindane gas.the diagnostic workup showed no other possible cause, and findings of liver scintigraphy and clinical manifestations were compatible with substance-induced cirrhos...

Journal: :jundishapur journal of natural pharmaceutical products 0
heibatullah kalantari nanotechnology research center, department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran anayatollah salimi nanotechnology research center, department of pharmaceutics, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; nanotechnology research center, department of pharmaceutics, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran. tel: +98-6113738381 anahita rezaie department of pathobiology, school of veterinary medicine, shahid chamran university, ahvaz, ir iran fereshteh jazayeri shushtari school of pharmacy, arvand international institute, ahvaz jundishapur university of medical sciences, ahvaz, ir iran mehdi goudarzi nanotechnology research center, department of pharmacology and toxicology, school of pharmacy, ahvaz jundishapur university of medical sciences, ahvaz, ir iran

background the development of drug delivery systems has improved the therapeutic and toxic properties of existing drugs in therapy. microemulsion systems are novel vehicles for drug delivery, which have been developed in recent years. these systems are currently of interest to the pharmaceutical scientist because of their considerable potential to act as drug delivery vehicles by incorporating ...

2010
Kathryn M. Chu Andrew M. Boulle Nathan Ford Eric Goemaere Valerie Asselman Gilles Van Cutsem

BACKGROUND The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen containing stavudine, lamivudine, and nevirapine. One of the primary concerns with the use of this regimen is nevirapine-associated hepatotoxicity. METHODOLOGY/PRINCIPAL FINDINGS Study participants were 1809 HIV-infec...

2005
Carlo Torti Giuseppe Lapadula Salvatore Casari Massimo Puoti Gian Pietro Cadeo Daniele Bella Giuseppe Pastore Nicoletta Ladisa Lorenzo Minoli Giovanni Sotgiu Francesco Mazzotta Sergio Lo Caputo Giovanni Di Perri Gaetano Filice Giampiero Carosi Spedali Civili

Background: The risk of hepatotoxicity associated with different HAART regimens (multiple-PI, single-PI or NNRTI-based) in HCV co-infected patients has not been fully assessed. Methods: Retrospective analysis of a prospective cohort of 1,038 HIV/HCV coinfected patients who commenced a new HAART in the Italian MASTER database. Patients were stratified into naïve (N) and experienced (E) to antire...

Journal: :Annals of hepatology 2012
Rolf Teschke Christian Frenzel Xaver Glass Johannes Schulze Axel Eickhoff

Herbal hepatotoxicity is a rare and poorly described disease because reported cases are mostly scattered and lack an appropriate causality assessment. We now describe in detail the clinical picture of herbal hepatotoxicity by extracts of Greater Celandine (GC), syn. Chelidonium majus L. from the Papaveraceae family, which contain more than 20 ingredients including various biologically active is...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2005
Kristina K Wolf Sheryl G Wood Jane A Hunt Brooke W Walton-Strong Kazuto Yasuda Lubin Lan Su X Duan Qin Hao Steven A Wrighton Elizabeth H Jeffery Ronald M Evans Juliana G Szakacs Lisa L von Moltke David J Greenblatt Michael H Court Erin G Schuetz Peter R Sinclair Jacqueline F Sinclair

The pregnane X receptor (PXR) is a transcriptional regulator of xenobiotic metabolizing enzymes, including cytochrome P450 3A (CYP3A), and transporters. Pretreatment of mice and rats with inducers of CYP3A increases acetaminophen (APAP) hepatotoxicity. In untreated mice, the amount of hepatic CYP3A11 mRNA is 4-fold greater in PXR(-/-) mice compared to wild-type mice (Guo et al., 2003), a findin...

Journal: :Annals of hepatology 2013
Rolf Teschke Axel Eickhoff Albrecht Wolff Christian Frenzel Johannes Schulze

Herbal hepatotoxicity is a rare but highly disputed disease because numerous confounding variables may complicate accurate causality assessment. Case evaluation is even more difficult when the WHO global introspection method (WHO method) is applied as diagnostic algorithm. This method lacks liver specificity, hepatotoxicity validation, and quantitative items, basic qualifications required for a...

2014
Vicente Sperb Antonello Dimas Alexandre Kliemann Breno Riegel Santos Cristiane Valle Tovo

Introduction: Liver disease caused by hepatitis C virus (HCV) is a major cause of morbidity in HIV patients. This study investigates the possibility that chronic HCV increases the risk of hepatotoxicity after highly active antiretroviral therapy (HAART) initiation. Methodology: The data from 30 coinfected HIV/HCV and 35 HIV monoinfected patients between August 2008 and August 2010, since the st...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید